MedPath

RAT and FES Effects on Upper Limb Motor Function in Subacute Stroke Patients

Not Applicable
Suspended
Conditions
Motor Function
Interventions
Device: Functional Electrical Stimulation
Device: Hand Robotic-Assisted Therapy
Registration Number
NCT05570838
Lead Sponsor
Neuron, Spain
Brief Summary

Stroke is one of the leading causes of mortality worldwide and is the leading cause of disability. Currently, a large number of novel treatments are emerging with the aim of recovering the highest functionality and quality of life for these patients, including Robot Assisted Therapy (RAT) and functional electrostimulation (FES). The aim of this study is to observe the effect of FES with respect to conventional treatment and RAT for the improvement of motor function of the upper limb. For this purpose, a clinical trial will be carried out in which participants will be divided into two groups, a first group that will receive conventional treatment together with RAT and FES and a second group that will only receive conventional treatment combined with RAT. The hypothesis of the research group is that the group receiving conventional treatment together with RAT and FES will obtain greater improvements in motor function.

Detailed Description

On the first day, participants will be asked to sign the informed consent form and the inclusion and exclusion criteria will be reconfirmed. Subsequently, manual grip strength, terminal opposition grip strength, subterminal opposition grip strength, subterminal opposition grip strength, subterminal-lateral grip strength and tridigital grip strength will be assessed using a JAMAR dynamometer. After this, the CAVIDACE quality of life scale and the FIM-FAM functional independence scale will be completed. Finally, motor function assessment will be carried out with the ARAT.

After the end of the treatment, the reassessment will be carried out and the initial assessments will be repeated. Subsequently, study participants will be followed up telematically, assessing quality of life using the CAVIDACE scale. Follow-up will be carried out 3 and 6 months after the end of treatment.

The data collected will be stored in a database created for this purpose with the Microsoft Access programme. Subsequently, they will be analysed using the SPSS/PC statistical programme. An exploratory analysis of all the information collected will be carried out for descriptive purposes; qualitative variables will be analysed using percentages, while quantitative variables will be analysed using mean and standard deviation. In both cases, the confidence intervals will be 95%.

After verifying whether the distribution of the data is normal or not, the hypothesis tests indicated in each case will be applied (χ2, Student's t, ANOVA, etc.). A significance level of 0.05 will be used for hypothesis testing. All analyses will be performed on an intention-to-treat basis.

Recruitment & Eligibility

Status
SUSPENDED
Sex
All
Target Recruitment
70
Inclusion Criteria
  • Acquired brain damage (caused by stroke or TBI) with less than one year of evolution.
  • Upper limb impairment and a score on the FMA-UE scale >11 and <55.
  • To present a stable clinical condition.
  • Have no other neurological or disabling pathology or previous dependence.
  • Agree to participate in the study and sign the informed consent form.
Exclusion Criteria
  • Having suffered epileptic seizures within 6 months prior to the start of the study.
  • Pain >5 on the Visual Analogue Scale (VAS) or the Verbal Numerical Scale (VNS).
  • Score <21 points on the Mini-Mental State Examination scale.
  • Failure to sign the informed consent form.
  • Occurrence of adverse events during or after the sessions.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
FES + conventional treatmentFunctional Electrical Stimulation60 minutes per session, 5 sessions per week with 30 minutes of task-specific training using Functional Electrical Stimulation applyed by Fesia Grasp device and 30 minutes of Robotic-Assisted Therapy using Amadeo robot for hand rehabilitation
Conventional treatmentHand Robotic-Assisted Therapy60 minutes per session, 5 sessions per week with 30 minutes of task-specific training and 30 minutes of Robotic-Assisted Therapy using Amadeo robot for hand rehabilitation
FES + conventional treatmentHand Robotic-Assisted Therapy60 minutes per session, 5 sessions per week with 30 minutes of task-specific training using Functional Electrical Stimulation applyed by Fesia Grasp device and 30 minutes of Robotic-Assisted Therapy using Amadeo robot for hand rehabilitation
Primary Outcome Measures
NameTimeMethod
Upper limb motor functionChange from Baseline in upper limb motor function at 6 weeks

the ability to learn or demonstrate the ability to acquire, maintain, modify and control voluntary postures and movement patterns with a goal framed motor behaviour. It will be measured wit the Action Research Arm Test (ARAT). This test asses the motor dexterity of the patient by 4 subtest based on functional movements (grasping, holding, clamping and gross movement

Secondary Outcome Measures
NameTimeMethod
Manual grip strengthChange from Baseline in manual grip strength at 6 weeks

strength is the ability of a muscle or group of muscles to generate tension during maximum dynamic or static effort in relation to the demands placed upon it. In this way, the capacity of the flexor muscles of wrist and finguers will be measured using a manual dynamometer

Quality of life measured with CAVIDACE questionnaire (Evaluación de la Calidad de Vida de personas con Daño Cerebral)Change from Baseline in quality of life at 6 weeks 3 months and 6 months

multidimensional phenomenon composed of 8 domains: emotional well-being, physical well-being, material well-being, self-determination, interpersonal relationships, social inclusion, personal development and individual rights. CAVIDACE questionnaire will be used to asses quality of life.The scale score ranges from 0 to 120, with higher scores corresponding to a higher quality of life.

Pinch strengthChange from Baseline in pinch strength at 6 weeks

strength is the ability of a muscle or group of muscles to generate tension during maximum dynamic or static effort in relation to the demands placed upon it. In this way, the capacity of the flexor muscles of finguers will be measured using a pinch dynamometer

Functional IndependenceChange from Baseline in functional independence at 6 weeks

Functional independence refers to the person's ability to carry out functional activities of daily living without the assistance of others. The FIM-FAM test will be used to asses the functional independence in this population

Trial Locations

Locations (1)

Neuron Mercedes

🇪🇸

Madrid, Spain

© Copyright 2025. All Rights Reserved by MedPath